Tilray

Tilray, established in 2018, is a prominent entity within the Pharmaceuticals and Healthcare sectors. The company focuses on the comprehensive research, cultivation, production, and distribution of medical cannabis and cannabinoids. Operating from its headquarters in Leamington, Ontario, Canada, Tilray has positioned itself as a key player in a rapidly evolving global market. Its strategic approach involves developing a diverse portfolio of products aimed at addressing various patient needs and promoting overall wellbeing.

With a workforce ranging from 1,000 to 5,000 employees, Tilray manages operations across 3 distinct locations. The company's commitment to innovation is evident in its product development, which spans consumer and medical applications. Meet Tilray's team to understand the expertise driving its growth and operational efficiency. Tilray's global footprint is expanding, with a presence in key markets and a focus on delivering high-quality, certified products. The company leverages state-of-the-art facilities for its cultivation and production processes, ensuring compliance and product integrity.

Tilray competes in a dynamic landscape alongside companies like Canopy Growth, Cronos Group, and major pharmaceutical players such as Pfizer and Merck. The company's revenue reached $858.3M, reflecting its significant market penetration. Learn about Tilray's global headquarters for detailed information on its operational base and geographic reach. Tilray's strategic initiatives include international market expansion and the development of innovative cannabis-derived products for medical and wellness applications. The company's ticker symbol is NASDAQ: TLRY.